JANX JANUX THERAPEUTICS INC Capital Structure Changes 8-K Filing 2023 - Equity Offerings Janux Therapeutics, Inc. has entered into an underwriting agreement with BofA Securities, Inc for the issuance and sale of over 4 million shares and pre-funded warrants, with the expected gross proceeds from the offering to be approximately $60 million.Get access to all SEC 8-K filings of the JANUX THERAPEUTICS INC